1. Home
  2. COCH vs INCR Comparison

COCH vs INCR Comparison

Compare COCH & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.64

Market Cap

47.1M

Sector

Finance

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.83

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCH
INCR
Founded
1995
1994
Country
United States
Israel
Employees
47
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.1M
47.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
COCH
INCR
Price
$0.64
$0.83
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
117.1K
39.7K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.58
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.68
52 Week High
$1.91
$1.77

Technical Indicators

Market Signals
Indicator
COCH
INCR
Relative Strength Index (RSI) 42.03 50.58
Support Level $0.63 $0.72
Resistance Level $0.73 $0.93
Average True Range (ATR) 0.04 0.06
MACD -0.00 0.00
Stochastic Oscillator 15.98 41.24

Price Performance

Historical Comparison
COCH
INCR

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: